MD2851G2 - Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer - Google Patents

Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer

Info

Publication number
MD2851G2
MD2851G2 MDA20040199A MD20040199A MD2851G2 MD 2851 G2 MD2851 G2 MD 2851G2 MD A20040199 A MDA20040199 A MD A20040199A MD 20040199 A MD20040199 A MD 20040199A MD 2851 G2 MD2851 G2 MD 2851G2
Authority
MD
Moldova
Prior art keywords
aqua
cobalt
bis
inhibitor
myeloid leukemia
Prior art date
Application number
MDA20040199A
Other languages
Romanian (ro)
Russian (ru)
Other versions
MD2851F1 (en
Inventor
Аурелиан ГУЛЯ
Дональд ПОЙРИЕР
Дженни РОЙ
Лилия ПОПОВСКИ
Виктор ЦАПКОВ
Original Assignee
Государственный Университет Молд0
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Университет Молд0 filed Critical Государственный Университет Молд0
Priority to MDA20040199A priority Critical patent/MD2851G2/en
Publication of MD2851F1 publication Critical patent/MD2851F1/en
Publication of MD2851G2 publication Critical patent/MD2851G2/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the application of coordinative combinations in medicine, namely to the use of monohydrate (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt as inhibitor of human myeloid leukemia.Summary of the invention consists in that as inhibitor of human myeloid leukemia is claimed (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloroacetato)cobalt monohydrate of the formula:The result of the invention consists in the establishment at the known (µ-aqua)-bis-(µ-trichloroacetato)-tri(aqua)cobalt-aqua-bis-(trichloro-acetato)cobalt monohydrate of the anticancer activity, exceeding 1,25…1,35 times the analogous characteristics of the dimeric trihydrate of aquaethylene-diaminetetraacetatobismuthate (III) of 1,6-dimitrotetraaminecobalt (III) and dehydrate of ethylenediaminetetraacetatobismuthate (III) of oxalatotetraaminecobalt (III) (of the analogue).
MDA20040199A 2004-08-12 2004-08-12 Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer MD2851G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20040199A MD2851G2 (en) 2004-08-12 2004-08-12 Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20040199A MD2851G2 (en) 2004-08-12 2004-08-12 Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer

Publications (2)

Publication Number Publication Date
MD2851F1 MD2851F1 (en) 2005-09-30
MD2851G2 true MD2851G2 (en) 2006-04-30

Family

ID=35057542

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20040199A MD2851G2 (en) 2004-08-12 2004-08-12 Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer

Country Status (1)

Country Link
MD (1) MD2851G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4215C1 (en) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3098G2 (en) * 2006-01-03 2007-02-28 Государственный Университет Молд0 Dihydrate of di( -Ophenoxy)-di[N-(2-oxy-1-benzal)-N1- -oxyfuralhydrazine(2-)copper] with properties of inhibitor of the human myeloid leukemia

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2786G2 (en) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD2786G2 (en) * 2004-05-11 2006-02-28 Государственный Университет Молд0 Inhibitors of human myeloid leukemia on base of heteronuclear coordinative compounds of cobalt(III) and bismuth(III)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4215C1 (en) * 2012-07-09 2013-11-30 Государственный Университет Молд0 Inhibitor of human myeloid leukemia based on N-(4-(5-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-3-yl)phenyl)-2-(pyridin-2-ylmethylen)-hydrazinecarbothioamide

Also Published As

Publication number Publication date
MD2851F1 (en) 2005-09-30

Similar Documents

Publication Publication Date Title
GEP20043322B (en) C7 Ester Substituted Taxanes as Antitumor Agents, Pharmaceutical Compositions Containing the Same and Use Thereof for Inhibiting Tumors
CA2463294A1 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
UA74443C2 (en) 5-HT receptor ligands and their use
YU4602A (en) Preserved pharmaceutical formulations
EP2223922A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
PL1791532T3 (en) Composition in micro-pellets with controlled release of physiologically active substances, procedure for their preparation and use in the zootechnical sector
GB2420559B (en) Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
MY140398A (en) 4-AMINO-6-PHENYL-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES
HRP20080689T3 (en) Imidazoline derivatives having cb1-antagonistic activity
MX2007003013A (en) Bicyclic amides as kinase inhibitors.
EP2014669A3 (en) Compositions and methods for cancer
GEP20094844B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
EP1962843A4 (en) Use of parp-1 inhibitors
EP2392322A3 (en) Dosing regimes for trans-clomiphene
EP1623985A3 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventative agents
GEP20094843B (en) 3-aminocyclopentane carboxamides as modulators of chemokine receptors
MXPA06003222A (en) Antimutor agent comprising a histone deacetylase inhibitor and a topoisomerase ii inhibitor.
WO2003106384A3 (en) Novel boronic chalcone derivatives and uses thereof
IL159993A0 (en) Platinum complexes and their use in cancer treatment
MD2851G2 (en) Inhibitor of human myeloid leukemia on base of asymmetric cobalt trichloroacetate dimer
PT1718651E (en) 7h-pyrrolopyrimidine derivatives
TW200504042A (en) Combretastatin derivatives with cytotoxic action
MXPA04001655A (en) Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof.
AU2003271807A8 (en) Compositions intended for the treatment of peripheral neuropathies, preparation thereof and uses of same
ATE491695T1 (en) TRICYLIC 1,2,4-TRIAZINE OXIDES AND COMPOSITIONS THEREOF FOR THERAPEUTIC USE IN CANCER TREATMENT

Legal Events

Date Code Title Description
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees